PNC Financial Services Group
DNA icon

PNC Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History

PNC Financial Services Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.6K Buy
986
+542
+122% +$4.42K ﹤0.01% 4068
2026
Q2 		$4.4K Buy
444
+85
+24% +$711 ﹤0.01% 4438
2026
Q1 		$2.2K Buy
359
+294
+452% +$2.44K ﹤0.01% 4550
2025
Q4 		$540 Sell
65
-151
-70% -$1.63K ﹤0.01% 4818
2025
Q3 		$3.15K Sell
216
-28
-11% -$335 ﹤0.01% 4370
2025
Q2 		$2.74K Sell
244
-34
-12% -$263 ﹤0.01% 4320
2025
Q1 		$1.58K Sell
278
-200
-42% -$2.04K ﹤0.01% 4406
2024
Q4 		$4.69K Hold
478
– – ﹤0.01% 4055
2024
Q3 		$3.9K Sell
478
-72
-13% -$721 ﹤0.01% 4111
2024
Q2 		$7.35K Sell
550
-397
-42% -$11.8K ﹤0.01% 3883
2024
Q1 		$44K Buy
947
+31
+3% +$1.6K ﹤0.01% 3050
2023
Q4 		$61.9K Buy
916
+114
+14% +$6.98K ﹤0.01% 2860
2023
Q3 		$58.1K Buy
802
+175
+28% +$14K ﹤0.01% 2874
2023
Q2 		$46.6K Buy
627
+49
+8% +$2.9K ﹤0.01% 3094
2023
Q1 		$30.7K Sell
578
-400
-41% -$25.3K ﹤0.01% 3262
2022
Q4 		$66.1K Sell
978
-152
-13% -$14K ﹤0.01% 2811
2022
Q3 		$142K Buy
1,130
+552
+96% +$65.8K ﹤0.01% 2311
2022
Q2 		$55K Buy
578
+284
+97% +$34.6K ﹤0.01% 2932
2022
Q1 		$47K Buy
294
+194
+194% +$37.8K ﹤0.01% 3142
2021
Q4 		$34K Buy
+100
New +$47.5K ﹤0.01% 3314

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

PNC Financial Services Group's DNA Position: Q3 2026 in Review

PNC Financial Services Group increased its Ginkgo Bioworks (DNA) stake by 122% in Q3 2026, buying an estimated $4.42K and bringing the position to 986 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.

PNC Financial Services Group first reported a position in DNA in Q4 2021 and has held it in 20 quarters since. The position peaked at $142K in Q3 2022. 100 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • PNC Financial Services Group held 986 shares of Ginkgo Bioworks worth $12.6K as of Q3 2026.
  • PNC Financial Services Group bought 542 Ginkgo Bioworks shares in Q3 2026, an estimated $4.42K.
  • Ginkgo Bioworks made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4068 holding.
  • PNC Financial Services Group first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's Ginkgo Bioworks position peaked at $142K in Q3 2022.
  • 100 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.